Dr Reddy’s starts clinical trial of Sputnik V vaccine

- Hetero is likely to manufacture the vaccine primarily for the Indian market, but will not have distribution rights
- Dr Reddy’s plans to enrol 100 participants for phase 2 and 1,400 for the last stage.